Claim boundaries for ceramide and glucosylceramide body creams in the United States are governed by the FDA's cosmetic versus drug distinction, and getting this wrong can result in warning letters, import alerts, or retail delistings.
Allowable cosmetic claims describe how the product affects the appearance or feel of the skin without asserting a physiological change to skin structure or function at a drug-effect level. Safe phrasing in this category includes: 'visibly improves skin hydration,' 'helps skin feel softer and smoother,' 'supports a healthy-looking skin barrier,' 'reduces the appearance of dryness,' and 'with ceramides and glucosylceramide to help replenish skin's natural lipid content.' All of these describe a sensory or aesthetic outcome and stop short of a structure-function claim.
Drug-territory claims — ones that would require FDA pre-market approval — include: 'treats eczema,' 'heals dermatitis,' 'repairs the skin barrier' (the word 'repair' is borderline and context-dependent; 'help support the appearance of a healthier barrier' is safer), 'prevents atopic flare-ups,' and 'clinically proven to restore the stratum corneum.' These imply the product diagnoses, treats, or cures a skin disease.
The word 'clinically proven' or 'clinically tested' is not itself a drug claim but creates an implied efficacy standard — if used, you must be able to substantiate it with an actual clinical study. Dermatologist-tested is lower bar (a dermatologist evaluated it, not necessarily that they studied it), but even that claim should be documented.
For the EU, the European Commission's guidance on cosmetic product claims (Regulation 655/2013) requires that claims be truthful, evidenced, honest, fair, and informed. Six common criteria apply: legal compliance, truthfulness, evidential support, honesty, fairness, and informed decision-making. The EU is stricter than the US on requiring substantiation files for efficacy claims, even sensory ones.
Prop 65 in California is separate: it requires a warning if any listed chemical exceeds specified safe harbor levels. Fragrance-free ceramide creams with minimal colorant are generally low Prop 65 risk, but if you add a fragrance or certain preservatives, your regulatory consultant should run a Prop 65 screen.
Have your final claim set reviewed by a cosmetic regulatory consultant before printing labels — this review typically costs $500 to $1,500 and is one of the highest-ROI steps a new brand can take. AJ Cosmo Labs connects you with regulatory consultants as well as manufacturers, so you can handle both from one platform.
Read the full guide on Private Label Ceramide Body Cream Manufacturer Low MOQ →